John Paulson's top holdings (June 2026) include Perpetua Resources Corp. (PPTA), a development-stage mining firm focused on the exploration and restoration of gold and antimony sites in Idaho.

John Paulson is the president and portfolio manager of Paulson & Co., an investment management firm headquartered in New York. The firm specializes in merger arbitrage, event-driven, and value-oriented investment strategies across a variety of sectors, including natural resources and healthcare.

Perpetua Resources Corp. (PPTA)

Perpetua Resources Corp. is primarily engaged in the development and exploration of precious mineral properties in the United States. Its central project is the Stibnite Gold Project, which involves both mineral extraction and environmental restoration of a historic mining district. Perpetua Resources Corp. carries a market capitalization of $3.39B, and John Paulson's position is currently valued at $875.64M. Wall Street analysts have established a price target of $42.25 for the stock, while its discounted cash flow is calculated at $8.3 per share.

Here's an overview of John Paulson's trades in Perpetua Resources Corp.:

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for non-alcoholic steatohepatitis (NASH). Its lead product candidate, resmetirom, is a liver-directed selective thyroid hormone receptor-beta agonist. Madrigal Pharmaceuticals Inc currently has a market cap of $11.46B, with the value of John Paulson's holding standing at $692.29M. The company's discounted cash flow analysis suggests a value of $1.32K per share, and analysts have assigned a price target of $645.33.

Here's an overview of John Paulson's trades in Madrigal Pharmaceuticals Inc:

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc develops, manufactures, and markets a broad range of pharmaceutical, medical device, and over-the-counter products. The company's primary focus areas include gastroenterology, hepatology, dermatology, and ophthalmology. With a market capitalization of $2.0B, Bausch Health Companies Inc represents a holding in John Paulson's portfolio currently worth $392.65M. The discounted cash flow value for the company is recorded at $13.85 per share.

Here's an overview of John Paulson's trades in Bausch Health Companies Inc:

International Tower Hill Mines Ltd (THM)

International Tower Hill Mines Ltd is focused on the acquisition, exploration, and development of mineral properties in the state of Alaska. The company's main asset is its 100% interest in the Livengood Gold Project. The current value of John Paulson's holding in International Tower Hill Mines Ltd is $283.16M, while the company's total market cap stands at $561.17M. A discounted cash flow analysis for the firm indicates a value of $0.01 per share.

Here's an overview of John Paulson's trades in International Tower Hill Mines Ltd:

Novagold Resources Inc. (NG)

Novagold Resources Inc. is a mineral exploration company that focuses on the development of gold properties. Its principal asset is a 50% interest in the Donlin Gold project, an undeveloped gold deposit located in Alaska. Novagold Resources Inc. has a market cap of $3.76B, and John Paulson's position in the firm is currently valued at $233.43M. For this stock, analysts have set a price target of $13.4, and the discounted cash flow value is listed at -0.15.

Here's an overview of John Paulson's trades in Novagold Resources Inc.: